Lihua Elizabeth Budde

40PUBLICATIONS
197CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursImmunogenetics (incl. genetic immunology)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jun 24, 2026
CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete Remission.

|Apr 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease.

|Apr 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

|Mar 20, 2026
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis.

Nancy L Bartlett, Laurie H Sehn, Sarit Assouline

|Feb 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

Pageof 7

Frequent Collaborators

10 joint publications

Alex Herrera

7 joint publications

Nancy L Bartlett

6 joint publications

Matthew J Matasar

6 joint publications

John H Baird